nabu.science
MethodologyAboutContact

 

  • Snapshot
  • Key Claims
  • Strengths & Limitations
  • Commentary
  • From the Authors
  • Author Note / Field Feedback
  • Dimension breakdown
  • Impact Profile
Free · About 5 minutes
Report #NBU-3BE64AEF·Framework v5.9·Pipeline v0.4·Evaluated 08 Oct 2026·OECD: 3.3 Neurology and psychiatry·Subfield: Virology·Basis: Full text·Type: Observational cohort study

Neuroaxonal Injury in Acute HIV Infection and Following Immediate Antiretroviral Therapy.

Chan et al.Chan, Sacdalan, Pinyakorn et al.·2025·The Journal of infectious diseases·10.1093/infdis/jiaf583 ↗

Primary claim

CSF NFL was elevated (ie, >UNL) in 15%, 8%, and 7% of RV254 participants at weeks 0, 24, and 48 + respectively, versus 2% among PWoH.

Supported · directly reported frequencies, limited by convenience controls and sample-based follow-up comparisons
In brief

A valuable long-term CSF biomarker study identifies neuroaxonal injury after acute HIV, but its causal conclusion about ART exceeds the observational design.

ReliabilityCaveats4 of 4 checks completeRead the entry ↓
Fragile — the claim's weakest requirement is that the effect exists at all. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.
Abstract

BACKGROUND: This study evaluates the degree of neuroaxonal injury during acute HIV infection (AHI) in neuroasymptomatic individuals and the neuroprotective effect of antiretroviral therapy (ART) initiated during AHI, by measuring neurofilament light (NFL), glial fibrillary acidic protein (GFAP) and soluble triggering receptor expressed on myeloid cells 2 (sTREM2) in cerebrospinal fluid (CSF) samples collected during pre-ART AHI and at post-ART visits up to 5 years.

METHODS: RV254 cohort participants (99% male, median age 27 years) were enrolled during Fiebig I-V AHI. A subset completed optional lumbar punctures during pre-ART AHI (week 0, n = 136) and/or at post-ART visits with HIV suppression (weeks 24, 48, 96; and 240, n = 201). RV254 CSF NFL measurements were compared to those of 44 people without HIV (PWoH), both adjusted to a sampling age of 30, and to age-based upper normal limits (UNL).

RESULTS: RV254 participants demonstrated higher CSF NFL than PWoH at pre-ART AHI (P < .001), and post-ART weeks 24 (P < .001) and 48 or later (week 48+, P = .003). CSF NFL was elevated (ie, >UNL) in 15%, 8%, and 7% of RV254 participants at weeks 0, 24, and 48 + respectively, versus 2% among PWoH. During AHI, elevated CSF NFL was associated with later Fiebig stages (III-V) (P = .034), higher CSF HIV RNA (P = .012) and a smaller difference between HIV RNA in the plasma and CSF (P = .002). Additionally, CSF NFL increased with GFAP and sTREM2 during pre-ART AHI and post-ART visits (P < .050).

CONCLUSIONS: CNS injury may occur during AHI. Additionally, early ART alone is likely insufficient to provide complete neuroprotection.

Key Claims

Primary finding · Supported

CSF NFL was elevated (ie, >UNL) in 15%, 8%, and 7% of RV254 participants at weeks 0, 24, and 48 + respectively, versus 2% among PWoH.

Fragile — the claim's weakest requirement is that the effect exists at all. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.

directly reported frequencies, limited by convenience controls and sample-based follow-up comparisons

Abstract Results; Results, CSF Biomarker Outcomes
Quote verified
Secondary · Supported

RV254 participants demonstrated higher CSF NFL than PWoH at pre-ART AHI (P < .001), and post-ART weeks 24 (P < .001) and 48 or later (week 48+, P = .003).

consistent group differences, though optional sampling and repeated observations limit precision

Abstract Results; Results, CSF Biomarker Outcomes
Quote verified
Secondary · Supported

During AHI, elevated CSF NFL was associated with later Fiebig stages (III-V) (P = .034), higher CSF HIV RNA (P = .012) and a smaller difference between HIV RNA in the plasma and CSF (P = .002).

reported exploratory associations from a small elevated-NFL subgroup without multiplicity adjustment

Abstract Results; Results, Factors Associated with Abnormal CSF NFL During AHI; Table 2
Quote verified
Secondary · Tentative

The findings also indicate that ART is insufficient to provide complete neuroprotection for all PWH, even with the earliest initiation following transmission.

the observational cohort lacks a treatment-timing or untreated counterfactual

Conclusion
Quote verified

Derived from the full evaluation — not a separate score.

Strengths · Limitations

Strengths

#contribution

Rare long-term acute-HIV CSF dataset

CSF NFL is assessed during acute infection and after suppressive ART through week 240, extending the follow-up horizon beyond the studies discussed in the paper.

↳ Results, CSF Biomarker Outcomes; Discussion, Neuroaxonal Injury During Follow-Up

#methodological rigour

Controlled and blinded biomarker measurement

Samples were analysed by technicians blinded to clinical data, using single reagent batches with intra-assay coefficients of variation below 10%; NFL was age-adjusted against an established normal limit.

↳ Methods, Measurements of HIV RNA and Biomarkers

#positioning

Relevant limitations explicitly acknowledged

The Discussion identifies limited serial samples, a brief cognitive battery, standard-assay sensitivity, and restricted demographic generalisability, providing important boundaries for interpretation.

↳ Discussion, limitations paragraph

Limitations

#methodological rigour

Repeated observations lack statistical modelling

The week-48+ group pools weeks 48, 96, and 240, and 20 participants contributed multiple samples, yet the reported sample-level tests do not account for within-person correlation. This could alter effective sample sizes and P-values.

↳ Methods, Statistical Analysis; Results, CSF Biomarker Outcomes

#methodological rigour

ART conclusion lacks causal comparator

All cohort participants began ART during acute infection, with no untreated, delayed-treatment, or alternative-treatment counterfactual. The design therefore cannot establish that ART itself is insufficient for neuroprotection.

↳ Methods, Study Design and Participants; Conclusion

#application pathway

Limited clinical and population transfer

Elevated NFL was not associated with the measured cognitive or mood outcomes, and the cohort was 99% male with a median age of 27 in one setting. These features restrict immediate clinical interpretation and wider transferability.

↳ Abstract, Methods; Results, Tables 2–3; Discussion, limitations paragraph

Does this match your read? Add your assessment ↓

Nabu Commentary

The principal contribution is the unusually long CSF follow-up after ART initiated during acute HIV infection, with biomarker measurements extending to week 240. Confidence in the laboratory measurements is supported by blinded, single-batch assays and age adjustment, but optional sampling and convenience controls limit comparability. The analysis does not state how within-person dependence was handled despite pooled longitudinal samples, reducing confidence in post-ART precision. Most importantly, the descriptive cohort can show residual NFL elevation but cannot identify ART’s neuroprotective effect without a causal comparator.

Evaluate another paper

Free · About 5 minutes · Research preview

Author Note / Field Feedback

Nabu’s assessment, alongside the field’s view.

Are you an author of this paper?

Dimension breakdown

Evidence Score

Out of 5
012345
3.0±0.2

Contribution
3.7

The study contributes a comparatively large acute-HIV CSF NFL dataset and extends post-ART sampling to 240 weeks. Its advance is meaningful but remains biomarker-specific and demographically narrow.

Discussion, opening paragraph and Neuroaxonal Injury During Follow-Up After Immediate ART Initiation During AHI

No studies to date have investigated the rate of elevated CSF NFL beyond 48 weeks following ART initiation during AHI.

Methodological Rigour
2.6

Blinded single-batch assays, age adjustment, suppression restrictions, and a male-only sensitivity analysis support measurement execution. Methodological Rigour is limited by optional sampling, convenience controls, unmodelled repeated observations, and a treatment-effect conclusion without a causal comparator.

Methods, Study Design and Participants; Measurements; Statistical Analysis; Results, CSF Biomarker Outcomes

RV254 participants underwent standard clinical and neuropsychiatric assessments, as well as optional lumbar punctures.

Reporting
3.4

The manuscript clearly separates pre-ART and post-ART analyses and presents the descriptive findings in a traceable sequence. The Conclusion nevertheless moves from group differences to the stronger statement that ART is insufficient for complete neuroprotection.

Abstract, Results and Conclusion

The findings also indicate that ART is insufficient to provide complete neuroprotection for all PWH.

Positioning
2.6

The Discussion engages prior NFL, CSF escape, immune-activation, and early-ART literature and acknowledges several study limitations. It does not frame the absent treatment counterfactual as a limit on the ART claim and does not fully carry the serial-sampling limitation into its persistence language.

Discussion, Neuroaxonal Injury During Follow-Up; limitations paragraph; Conclusion

It lacks a sizable number of serial CSF samples collected before and after ART.

Reliability

Caveats4 of 4 checks


Results checkClean

The reported numbers and statistics are consistent with the stated results.

Reporting and transparencyNoted

Parent-cohort registration is identified, but preregistration of the analytic plan is not reported; the post-ART subgroup analysis is explicitly exploratory.

Conflict of interest: not stated · Ethics approval: declared · Data availability: not stated · Code availability: not stated

Reference IntegrityClean

49 references in manuscript 49 of 49 checkable references found in an index

References not verified automatically are resolved manually within 24 hours.

Post-Publication RecordClean

No retraction or expression of concern found in Crossref (includes Retraction Watch).

Last checked: 17 Oct 2026

Sources: Crossref (incl. Retraction Watch) ✓

Impact Profile

Impact areaHealth · Infection · HIV/AIDS
Type of advanceEmpirical
Route to useSuggested
AdvanceExtends
BeneficiariesLarge
CitationsToo early
Policy · patentNot yet traced
ReachedNot reachedNot assessable or unverified
ReadinessFoundational
Foundational
Controlled
Piloted
Validated
Implementable
FoundationalImplementable

The primary claim rests on observational biomarker measurements in a single cohort with non-randomized immediate ART and no untreated comparison group, so it is a descriptive observation rather than a demonstrated effect.

From the paper
“This information is crucial not only for the HIV community but also for clinicians and policymakers”

The paper names clinicians and policymakers as interested parties but describes no specific decision, intervention, or action they would take based on these findings, while the conclusion mainly calls for future studies.

Pathway

Clinicians caring for people with HIV could use CSF NFL monitoring to identify ongoing CNS injury despite suppressive ART and to inform adjunctive neuroprotective management decisions.

Barrier

Elevated NFL was not linked to any measurable cognitive or mood outcome, so without evidence of clinical consequences or a proven intervention, routine use remains unjustified.

Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3

Report an issue →

AI-generated, human-governed. Something look off? Contact us to request a review.

Keep reading

Related evaluations

Other papers Nabu has evaluated blind, starting with the same field.

  1. Longitudinal changes in plasma biomarkers of immune activation, neuronal inflammation and injury in persons with HIV initiating ART

    Henderson, Dutey-Magni, Herrera, et al. · 2026 · Clinical medicine

    Primary claim

    Plasma biomarkers of brain health improved following 2 years of ART.

    Tentative
    Evidence Score
    3.1±0.2
    Reliability
    No concerns
  2. (Dis)similarities between the Decidual and Tumor Microenvironment

    Krstic, Deutsch, Fuchs, et al. · 2022 · Basic medicine

    Primary claim

    Trophoblast and tumor cells are both supported by an abetting microenvironment (Figure 1) that influences/regulates invasion, angiogenesis, and immune tolerance/evasion, among others.

    Supported
    Evidence Score
    3.2±0.1
    Reliability
    Caveats
  3. Early human trophoblast development: from morphology to function

    Gauster, Moser, Wernitznig, et al. · 2022 · Basic medicine

    Primary claim

    It seems as if only this multinucleated layer [the primitive syncytiotrophoblast] is able to penetrate the uterine epithelium and allows embedding of the embryo into the uterine stroma

    Tentative
    Evidence Score
    3.4±0.1
    Reliability
    No concerns

How the rubric works →